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Nonalcoholic steatohepatitis is one of the leading causes of liver disease. Dietary factors determine the clinical presentation of
steatohepatitis and can influence the progression of related diseases. Cholesterol has emerged as a critical player in the disease and
hence consumption of cholesterol-enriched diets can lead to a progressive form of the disease.The aimwas to investigate the impact
of liver cholesterol overload on the progression of the obstructive cholestasis in mice subjected to bile duct ligation surgery. Mice
were fed with a high cholesterol diet for two days and then were subjected to surgery procedure; histological, biochemical, and
molecular analyses were conducted to address the effect of cholesterol in liver damage. Mice under the diet were more susceptible
to damage. Results show that cholesterol fed mice exhibited increased apoptosis and oxidative stress as well as reduction in cell
proliferation.Mortality following surgery was higher inHC fedmice. Liver cholesterol impairs the repair of liver during obstructive
cholestasis and aggravates the disease with early fatal consequences; these effects were strongly associated with oxidative stress.
1. Introduction
Obesity is an epidemic problem; it has become a global
health concern affecting rich and poor countries [1]. Obesity
is the primary cause of nonalcoholic fatty liver disease
(NAFLD), the commonest disease that affects liver function.
It is highly prevalent and results from excessive fat accumu-
lation, particularly free fatty acids, triglycerides (TG), and
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cholesterol [2], inducing a wide range of biochemical and
clinical consequences leading to sensitization to damage and
running to progressive disease stages such as nonalcoholic
steatohepatitis (NASH), and fibrosis [3]. While the two-hit
hypothesis posits that fat accumulation is key for progressive
NAFLD, some of our studies have suggested that the kind of
lipid rather than the amount of fat determines the susceptibil-
ity to secondary hits, including inflammatory cytokines such
as the TNF-𝛼 family [4].
Although cholesterol is a critical component of mem-
brane bilayers, its accumulation disrupts membrane fluidity
or dynamics and promotes cellular dysfunction that could
lead to disease progression [5]. The liver plays key role in
the maintenance of cholesterol homeostasis, whose levels are
determined by de novo synthesis and supply from the diet
by serum lipoproteins [6]. Increased cholesterol deposition
in the liver, in particular its accumulation in mitochondria,
has emerged as one of the main toxic lipids in NAFLD
due to cholesterol dependent mitochondrial dysfunction and
sensitization to oxidative stress and inflammatory cytokines
secondary tomitochondrial GSH depletion [4, 7–9].The sen-
sitization to the damagemediated by cholesterol overload can
occur independently of nutritional oversupply as ob/ob mice
and Niemann-Pick type C1- (NPC1-) lacking mice exhibit
increasedmitochondrial cholesterol accumulation and sensi-
tization to inflammatory cytokines-mediated oxidative stress
and cell death [4]. In line with these findings, there has
been evidence that cholesterol intake increases the risk and
severity ofNAFLDand that patientswithNASHhave a higher
expression of StARD1, a cholesterol transporting protein that
regulates mitochondrial cholesterol homeostasis [8, 10, 11].
Despite this knowledge, the role of hepatic cholesterol
accumulation in cholestatic liver disease has not been thor-
oughly examined. Hepatic accumulation of bile acids due
to impairment in bile flow is central to the pathogenesis of
cholestasis liver disease and leads to hepatic injury and, in
severe cases, organ failure [12]. Bile acids’ accumulation exerts
noxious cellular events, ranging from oxidative stress and
inflammation to apoptosis and necrosis [13, 14], leading to
acute liver toxicity, proliferation of bile ducts, and fibrosis that
eventually progresses to cirrhosis and liver failure. Moreover,
it has been reported that patients with NAFLD exhibit
alterations in bile acids homeostasis [15], suggesting that
hepatic steatosis may determine the clinical presentation of
cholestatic liver disease.
In the present work we addressed the impact of liver
cholesterol overload in the BDL model of obstructive
cholestasis. Our data show that nutritional hepatic cholesterol
accumulation sensitizes to BDL-mediated liver injury and
death.
2. Material and Methods
2.1. Animal Models. C57BL/6 male mice (8–10 weeks old)
were purchased from Jackson Laboratory (Bar Harbor,
Maine, USA) and were maintained in pathogen-free condi-
tions with controlled temperature and humidity on a 12 h
light-dark cycle in the animal care facility at the Universidad
Auto´noma Metropolitana and the Medical School of Uni-
versitat de Barcelona. The experimental protocols used were
approved and performed in accordancewith theAnimal Care
Committee of the University of Barcelona.
2.2. Experimental Design. Forty C57BL/6 mice were sepa-
rated into two diet groups; the first one was fed with a high
cholesterol (HC) (2% cholesterol, 0.5% sodium cholate) diet
for two days as previously reported [4, 16]; the second group
was fed with control standard Chow diet for the same period
of time. Animals received water ad libitum. Afterwards, each
group was subject to bile duct ligation (BDL) surgery or
control Sham procedure. Five mice per time were sacrificed
at days 1, 2, and 3, after surgery as depicted in Supplementary
Figure 1(A) of the Supplementary Material available online
at http://dx.doi.org/10.1155/2016/9895176. Five Sham animals
were sacrificed only at day three. Liver tissue and serum
were recovered for analysis. Six extra animals were used to
figure out the effect of sodium cholate alone; we used a
diet supplemented with 0.5% of the salt for 2 and 30 days
(three mice per time) and liver gross inspection and AST and
ALT serum activities were also determined (Supplementary
Figures 1(B) and 1(C)).
2.3. BileDuct Ligation Surgery. Surgerywas performedunder
aseptic conditions. Anesthesia was induced with 2% isoflu-
rane (Abbott Laboratories #B506) and 2-liter/min oxygen
flow for a mouse of 25 g body weight. After median laparo-
tomy, the common bile duct was ligated close to the liver
hilus, below the bifurcation with 4-0 silk suture (Ethicon),
to impede bile flow. The gallbladder was left intact. The
abdominal muscle was sutured with a 5-0 surgical silk suture
and the wound was closed with surgical staples. Control mice
underwent a Sham surgery without BDL. All animals were
allowed to wake up on a heating pad, and analgesia was given
to all animals.
2.4. Determination of Liver Function Tests. Blood samples
were obtained from the portal vein under isoflurane anesthe-
sia before sacrifice. Serum levels of alanine aminotransferase
(ALT), aspartate aminotransferase (AST), and alkaline phos-
phatase (ALP) were determined by the automated method
using Reflovet Plus (Roche, Mannheim, Germany).
2.5. Histology and Immunohistochemical Studies. Liver tis-
sue was fixed in 10% formalin/phosphate-buffered saline,
dehydrated in alcohols, incubated in xylene, and embedded
in paraffin. Paraffin molds containing liver sections were
cut into 5 𝜇m sections and mounted on HistoGrip-coated
slides. H&E was performed following standard procedures.
Apoptosis was addressed by TUNEL detection kit (Trevigen
Inc.) according to the manufacturer’s protocol. Oil Red O
(ORO) solution was used to detect neutral lipids in tissue.
For the immunohistochemistry of Ki67, paraffin sections
were antigen unmasked with citrate buffer. Endogenous
peroxidases were blocked with 3% H
2
O
2
; afterward slides
were incubated with primary antibody overnight in a wet
chamber at 4∘C. After rinsing with PBS 1x, the slides were
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incubated with a biotinylated antibody for 45min in a wet
chamber and developed with the ABC kit with peroxidase
substrate (DAB) and peroxidase buffer. After rinsing with
tap water, slides were counterstained with hematoxylin. For
filipin staining, frozen sections were fixed for 1 h at room
temperature with formalin 10%, washed with PBS, and
incubated with 0.2mg/mL filipin over night at 4∘C protected
from light. After 3 final washes in PBS, tissues were mounted
and confocal images (Carl Zeiss, LSM 780multiphoton, Jena,
Germany) were collected using UV excitation.
2.6. Cholesterol Determination. Ten mg of liver tissue or
200𝜇L of serum was saponified with alcoholic KOH in a
60∘C heating block for 15min. After the mixture had cooled,
2mL of hexane and 600 𝜇L of distilled water were added
and shaken to ensure complete mixing. Appropriate aliquots
of the hexane layer were evaporated under nitrogen and
used for cholesterol measurement with O-phthalaldehyde
reagent (Sigma-Aldrich) dissolved in acetic acid; after that
sulfuric acid was added and then read at 550 nm in the
spectrophotometer.
2.7. Triglycerides Determination. Triglyceride (TG) content
was determined using the triglycerides determination kit
(Sigma-Aldrich, San Louis, MO) following the manufacture’s
instructions.
2.8. Western Blot. Western blotting was performed follow-
ing the protocol previously reported by Clavijo-Cornejo
et al. [17]. Briefly, total proteins were isolated from liver
homogenate with T-PER (Pierce) extraction reagents, sup-
plemented with protease and phosphatase cocktail inhibitors
(Roche Inc.). One hundred 𝜇g of total protein was sep-
arated on precast 4–20% gels (Invitrogen), transferred to
polyvinylidene difluoride membranes (PVDF, Invitrogen),
and probedwith different antibodies as shown in Supplemen-
tary Figure 2. Membranes were incubated with anti-mouse
or anti-rabbit horseradish peroxidase-conjugated secondary
antibody depending on the origin of the primary anti-
body. Immunoreactive bands were identified with ECL-Plus
Western blotting detection reagents (GE Healthcare). Equal
loading was demonstrated by probing the same membranes
with actin antibody (Sigma-Aldrich).
2.9. Caspase 3 Activity. Tissue was lysed in reaction buffer
and incubated for 30min on ice. For each reaction, caspase
3 synthetic fluorogenic tetrapeptide substrate (Ac-DEVD-
AMC)was added (BDPharmingen) and then the tissue lysate;
after that sampleswere incubated for one hour.The amount of
AMC released was measured by fluorometry at an excitation
wavelength of 380 nmand an emissionwavelength of 420 nm.
2.10. In Situ ROS Determination. Animals were sacrificed
in parallel exclusively for in situ ROS determination. Fresh
tissue was rapidly sectioned, frozen in liquid nitrogen,
and embedded in optimum cutting temperature compound
(OCT, Sakura Finetek, Torrance, CA); subsequently, 8𝜇m
frozen sections were obtained in a cryostat (Leica CM-
3050S, Heerbrugg, Switzerland) at −20∘C and the slides were
immediately incubated for 15min, in the dark, at room
temperature with either DCFH (5 𝜇M), a cell-permeable
nonfluorescent probe that is deesterified intracellularly and
converted to the highly fluorescent 2󸀠,7󸀠-dichlorofluorescein
upon oxidation by ROS, particularly peroxides (H
2
O
2
), or
with dihydroethidium(DHE, 50 𝜇M) for determination of
superoxide anion radical (O
2
−) detecting ethidium fluores-
cence. Samples were covered and observed using a confocal
microscope at excitation and emission wavelengths of 480
and 520 nm, respectively, for DCFH and 485 and 570 nm,
respectively, for DHE-derived ethidium fluorescence, as pre-
viously we reported [18].
2.11. Glutathione (GSH) Measurements. GSH levels in tissue
homogenates were analyzed by HPLC as previously we
reported [18].
2.12. Bilirubins Determination. Bilirubins content was
assayed by using Bilirubin Jendrassik-Grof FS kit (DiaSys
Inc.) following the manufacturer’s instructions.
2.13. Statistical Analysis. Data are presented as mean ± SEM
for at least four different animals, and each experiment was
carried out in triplicate. Comparisons between groups were
performed using the ANOVA test followed by a post hoc
Bonferroni test.
Additional materials and methods can be found in Sup-
plementary Material.
3. Results
3.1. AHighCholesterol Diet Induces Liver Steatosis. To address
the role of cholesterol hepatic overloading in BDL-mediated
liver injury, we fed mice with a diet enriched in cholesterol
(HC), as previously described [4, 16]. As seen, HC fed
mice exhibited the characteristic pale color of the steatotic
liver compared to mice fed with the control Chow diet
(Figure 1(a)). In addition, filipin and ORO staining in liver
tissue revealed a high content of both free cholesterol and
neutral lipids (Figure 1(b)), findings that were biochemically
confirmed in tissue homogenates (Figure 1(c)). Moreover, in
line with findings in intact liver, isolated hepatocytes from
HC fed mice revealed increased filipin and ORO staining
(Supplementary Figure 3), confirming the accumulation of
cholesterol and neutral lipids in parenchymal cells. This
steatotic phenotype was associated with liver injury, as
revealed by serum AST and ALT activities (Figure 1(d)).
3.2. Cholesterol Overload Sensitizes to BDL-Induced Liver
Damage andAggravatesObstructive Jaundice. Wenext exam-
ined the impact of HC feeding in BDL-induced liver injury
and survival. Mice fed with the HC diet and subjected to BDL
surgery died between 60 and 115 h after procedure, compared
to mice fed with control Chow diet (Figure 2(a)); none of the
HC fed mice survived beyond 5 days after BDL. Although
BDL is a model for acute obstructive cholestasis, control
mice survived up to 6 weeks after surgery, in agreement with
previous results [19, 20].
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Figure 1: A high cholesterol diet induces liver steatosis. (a) Macroscopic liver inspection of standard control Chow diet (Chow) and high
cholesterol (HC) diet. (b) Free cholesterol determination by filipin. (c) Neutral lipid determined by Oil Red O staining (ORO) in Chow
and HC liver sections. (d) Biochemistry determination in liver tissue of total cholesterol and triglycerides (TG) content. (e) Liver function
tests: aspartate aminotransferase (AST) and alanine aminotransferase (ALT). Each column represents mean ± SEM of three independent
experiments. Differences were considered significant at ∗𝑝 ≤ 0.01 versus Chow. Images are representative of at least three independent
experiments. Original magnification: 200x.
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As a high percentage of HC fed mice died within 3 days
after surgery, we decided to characterize liver function at 1, 2,
and 3 days after BDL to assess the mechanisms contributing
to the early death of HC fed mice.
Liver gross inspections revealed no significant differences
between groups; mice presented bile duct stasis and greenish
gallbladder in HC group, in comparison with Chow ani-
mals, which exhibited a darker gallbladder (Figure 2(b)).
Cholesterol content, assayed by filipin staining, increased in
HC animals. At day 3 cholesterol content was less diffused
in the tissue, displaying spots with high fluorescence, while
Chow fed animals liver cholesterol content was uniform and
unchanged following BDL.
Serum cholesterol and TG content were also elevated in
HC fed mice and remained increased after BDL. Liver injury
and function tests exhibited a significant increase in HC fed
mice since day one after BDL inAST andALT and at two days
in ALP. In all cases, values raised until day three in HC fed
mice. In contrast, Chow fed animals showed a slight increase
at day two in AST, and no significant changes were observed
up to the third day.
Figure 2(c) depicts the main biochemical tests to address
liver function and damage. Total and free bilirubins were also
increased in HC fed animals since the first day of surgery,
and a similar effect was observed in serum total bile acids
(TBA). Interestingly, liver TBA were significantly augmented
in Sham animals due to HC feeding with no changes in
the course of the study, while Chow fed animals exhibited
significantly increased liver TBA at day two, peaking at the
third day.
No significant changes were found in mice fed with a
diet supplementedwith 0.5% sodium cholate alone, as control
diet, and subjected to BDL comparing with Chow diet fed
animals.
In order to figure out the mechanism that could explain
the premature death in HC fed animals, we focused on
studying the phenotype and molecular changes at day three.
Histological analysis of livers fromHC fedmice (Figure 3)
revealed lymphocytes (black arrow head) infiltration and
prominent bridging hepatic necrosis seen in HC fed animals
comparing with Chow fed animals, which presented this
characteristic to a lesser extent. Chow fed animals presented
evidence of cell proliferation (white arrow head), suggesting
an ongoing repair process.
3.3. HC Feeding Decreases Cell Proliferation following BDL.
In order to address whether cholesterol loading interfered
with cell proliferation during BDL, as suggested by H&E
staining, we performed Ki67 staining in samples from both
groups of mice at the third day after BDL. Figure 4(b) shows
more positive Ki67 cells (black arrows) in liver samples from
Chow fed mice than liver from HC fed mice (Figure 4(d)).
Results were in agreement with the expression of the main
cell cycle proteins cyclins D1 and A and cdk2 and cdk4,
showing a sustained expression in a time-dependent manner
in Chow fed animals, particularly in cdk2 and cdk4, which
decreased in HC mice, particularly at day three. Cell cycle
inhibitory proteins, such as p27 and p21, presented different
comportment; p27 increased in time-dependent manner, but
p21 decreased (Figure 4(e)).
3.4. BDL in HC Fed Mice Induces Apoptosis and Oxidative
Stress. It is well known that bile salts’ accumulation in the
liver induces apoptosis in hepatocytes [21, 22]. Figure 5 shows
that HC fed mice subjected to BDL surgery presented more
apoptotic cells, assayed by TUNEL (Figure 5(d)), than Chow
fed animals (Figure 5(b)). The quantification of apoptotic
cells revealed a significant increment in positive cells in HC
fed animals (Figure 5(e)). These data were corroborated by
measurement of caspase 3 activity (Figure 5(f)).
Oxidative stress is one of the major inducers of hepatic
apoptosis [23]. Therefore, we measured the in situ content
of ROS by DCFH and DHE, as previously reported [18]. As
seen, DCFH and DHE staining increased in livers sections
from HC fed animals at day 3 after BDL, compared to Chow
fed animals (Figure 6(a)); these results were in agreement
with a decrease in total GSH levels (Figure 6(b)). GSH levels
decreased as a result of HC feeding and continued to decline
after BDL.
Importantly, Chow fed animals exhibited decreased GSH
content at day one of treatment, which subsequently aug-
mented at day two reaching basal GSH levels at the third day.
The analysis of the main antioxidant enzymes (Figure 6(c))
revealed an induction of 𝛾-GCS and GPX4 in Chow fed
animals at days two and three, an effect that was not observed
in HC animals; even more, GPX4 decreased in HC fed
animals in time-dependent manner. GPX1/2 were slightly
induced in HC fed mice. GST exhibited a time-dependent
increment in Chow fed animals, with opposite effect in HC
fed mice. Other antioxidant enzymes such as SOD1, SOD2,
and NQO1 showed an increment in Chow fed mice but not
so in HC fed mice; even more, SOD2 showed a decrease in
the time of the study in HC fed animals.
4. Discussion
Bile duct obstruction-mediated liver injury is a key feature
of cholestasis, which underlies several chronic liver diseases,
such as gallstone impaction, biliary atresia, and tumor com-
pression [24]. The accumulation of toxic bile acids during
bile duct obstruction contributes to the hepatocellular injury.
The mechanism of damage is complex and involves oxidative
stress generation and inflammation [14, 24, 25].
It is well known that bile acids arise from enzymatic
oxidation of cholesterol and that hypercholesterolemia lead-
ing to hepatic cholesterol accumulation is one of the key
hallmarks in NAFLD and NASH [8, 10]. Consumption of
cholesterol-enriched diets could aggravate NAFLD, particu-
larly in susceptible individuals related to congenital risks or
deficient dietary habits [26, 27]. For instance, in Hispanics,
the consumption of high cholesterol diets is very common,
which may account for the high prevalence of NAFLD in this
population [28].
In the presentworkwe used a nutritionalmodel of hepatic
cholesterol overload to examine the impact of cholesterol
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Figure 2: Cholesterol overload sensitizes to BDL-induced liver damage and aggravates obstructive jaundice. (a) Survival plot after BDL;
at least nine animals were considered for the survival experiment. (b) Liver gross inspection and free cholesterol determination by filipin.
Images are representative of at least three independent experiments. Original magnification for filliping staining: 100x. (c) Biochemical serum
cholesterol and triglycerides (TG) determination. Liver function test: aspartate aminotransferase (AST); alanine aminotransferase (ALT);
alkaline phosphatase (ALP); total bilirubin; direct bilirubin; serum total bile acids (TBA); and liver tissue TBA. Each column represents mean
± SEM of three independent experiments. Differences were considered significant at ∗𝑝 ≤ 0.01 versus Sham Chow and &𝑝 < 0.01 versus
Chow fed mice at the same time.
Oxidative Medicine and Cellular Longevity 7
Chow
Sh
am
(a)
HC
Sh
am
(b)
200x
Chow
3
d
(c)
200x
HC
∗
3
d
(d)
Figure 3: Cholesterol overload exacerbates liver tissue damage. Histology analysis by H&E staining. Liver tissue was obtained from animals
fed with standard Chow control diet (Chow) or high cholesterol (HC) diet for 2 days and subjected to BDL. Bridging hepatic necrosis areas
(asterisks), polymorphonuclear leukocytes and lymphocytes infiltration (black arrow head), inflammatory cells infiltration (arrow), and cell
proliferation (white arrow head). Representative images from at least four different animals. Original magnification: 200x.
in obstructive cholestasis-mediated liver injury. Mice fed a
HC-enriched diet for two days showed a steatotic phenotype
with particular lipid overload in hepatocytes, comprising
primarily increased cholesterol accumulation (2-3-fold), and
exhibited liver damage, as revealed by serum AST and ALT
values and histology examination. Although HC diet was
supplemented with 2% cholesterol, HC fed mice exhibited
a mild increase in TG content in hepatocytes. Whether TG
accumulation reflects increased FFA esterification into TG or
impairment in mitochondrial 𝛽-oxidation due to cholesterol
trafficking to mitochondria, as we reported previously [4],
remains to be further established.
In line with the emerging role of cholesterol in NAFLD
progression to NASH in mice and humans and the role of
cholesterol in liver fibrogenesis, we show the sensitization of
mice fed HC diet to BCL-mediated liver injury and prema-
ture death. Moreover, cholesterol overload exacerbates BDL-
induced deterioration of liver function, including increased
total and free bilirubin and TBA in serum since day one after
BDL, but not in Sham animals, indicating that this response is
a consequence of bile duct obstruction. Interestingly, hepatic
TBA content increased as a result of HC feeding, with no
significant further increment following BDL as opposed to
chow fed mice, which exhibit a time-dependent increase
in liver TBA, reaching similar values observed in HC fed
animals at day three. The toxic effect of bile acids is well
documented [21, 29, 30] and accumulation in the liver is one
of the main factors associated with cholestasis.
Besides accumulation of toxic bile acids, our data suggest
that cholesterol overload impairs cell proliferation and tissue
repair as revealed by Ki67 immunostaining. This response is
accompanied by decreased p21 expression levels in choles-
terol loaded livers and a compensatory increased expression
of cdk2. We observed that HC fed mice exhibit an increased
content of total bile acids, which are associated with cell
death.These findings suggest that cholesterol antagonizes the
reported protective effect mediated by FXR activation. In
support of this link, Cheng and coworkers recently reported
that FXR transgenic mice exhibited increased sensitivity to a
high cholesterol diet-induced hepatotoxicity [31], indicating
that FXR is unable to protect from cholesterol-mediated liver
injury.
On the other hand, it is well known that oxidative
stress mediates the deleterious effects of toxic bile acids and
cholesterol [9, 21, 25, 32]. Our findings are in agreement
with these observations, as HC fed mice exhibit increased
DCFH and DHE staining following BDL compared to Chow
fed mice. In line with previous findings linking choles-
terol accumulation in the liver with mitochondria-mediated
ROS generation and impairment in antioxidant defense, we
observed the downregulation of GPX4 and SOD2, two of the
main mitochondrial protective enzymes [17, 33] in HC fed
mice after BDL. Moreover, GST and 𝛾-GCS display a similar
behavior, strongly supporting the fact that the disruption in
GSH homeostasis is an important contributor to cholesterol-
mediated hepatocellular damage.
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Figure 4: Cholesterol excess impairs cell proliferation. Tissuewas obtained fromShamand three days after BDL animals, under (a-b) standard
Chow control diet (Chow) or (c-d) high cholesterol (HC) diet, and Ki67 immunohistochemistry was assayed; arrows show positive cells
(magnification at 100x). (e) Western blot and densitometric analysis of main cell cycle proteins. Actin was used as loading control; ∗𝑝 < 0.05
versus Sham Chow fed mice, &𝑝 < 0.05 versus Sham HC fed mice. Images are representative from at least four independent mice.
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Figure 5: BDL in HC fed mice increases apoptosis. Tissue was obtained from Sham and three days after BDL animals, under (a-b) standard
Chow control diet (Chow) or (c-d) high cholesterol (HC) diet, and apoptosis was assayed by (e) TUNEL immunohistochemistry; (e)
quantification of positive TUNEL cells or by (f) caspase 3 activity. Images are representative from at least four independent mice. Original
magnification: 100x. ∗𝑝 < 0.01 versus Chow fed mice, #𝑝 < 0.01 versus 3 days Chow fed mice, and &𝑝 < 0.01 versus HC fed mice.
It is clear that cholesterol overload in the liver aggravates
the organ injury decompensating GSH system, which could
be related to a rapid cell death, particularly by apoptosis,
potentiated by the overproduction of bile salts that eventu-
ally conducts to organ failure and animal death. Animals
subjected to sodium cholate alone diet do not exhibit any
significant change during the five days of the study.
It is clear that liver with cholesterol overload is sensitized
to damage aggravating the diseases; this could be partic-
ularly considered in patients with genetic susceptibility to
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Figure 6: HC diet increases oxidative stress in mice with BDL. (a) ROS content determined in fresh liver sections. Peroxides content was
assayed by DCFH (5 𝜇M) for 30min, and superoxide content was determined by DHE (50 𝜇M) for 30min. (b) GSH content determined by
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animals; &𝑝 ≤ 0.01 versus Sham Chow fed animals at the same time. Images are representative of at least three independent experiments.
Original magnification: 200x.
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cholesterol overload, such as early infantile forms of
Niemann-Pick C disease, where canonical liver insults must
be under surveillance.
Overall, our findings may be of clinical relevance sug-
gesting that patients with cholesterol liver overload can be
more at risk of developing clinical complications associated
with cholestasis. In this context the use of statins may be of
potential benefit by targeting the mevalonate pathway and
perhaps other noncholesterol relatedmechanisms involved in
cholestasis-mediated liver injury.
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